Please login to the form below

Not currently logged in
Email:
Password:

ethinylestradiol

This page shows the latest ethinylestradiol news and features for those working in and with pharma, biotech and healthcare.

Teva offloads women's health unit in quickfire deals

Teva offloads women's health unit in quickfire deals

CVC is paying $703m in cash for the bulk of the unit's products, which include fertility treatment Ovaleap (follitropin alfa), contraceptives Zoely (oestradiol/nomegestrol) and Seasonique (levonorgestrel/ethinylestradiol), menopause therapy

Latest news

  • Pharmaceuticals added to EU's pollutant 'watch list' Pharmaceuticals added to EU's pollutant 'watch list'

    The three chemicals are diclofenac, a commonly-used generic painkiller which is suspected of killing fish, and the hormones 17 alpha-ethinylestradiol (EE2) and 17 beta-estradiol (E2), which the EC

  • EMA starts contraceptive safety probe EMA starts contraceptive safety probe

    Leading third- and fourth-generation brands include Bayer's Meliane (ethinyl stradiol and gestodene) and Yasmin (ethinylestradiol and drospirenone) products, and have proved popular because they reduce side effects such as ... company's older Diane 35

  • Levest COC promises NHS cost savings

    Levest contains levenogesterel 150μg and ethinylestradiol 30μg and costs £2.55 per 63 tablets, or the equivalent of just £0.85 per cycle. ... This makes it 10 per cent cheaper than competitor, Microgynon 30 (ethinylestradiol and levonorgestrel),

  • New oral contraceptive launched in Europe

    Oral contraceptives available to women up until now have contained the oestrogen component ethinylestradiol.

  • Improved attack

    US. Ethinylestradiol/levonorgestrel 20? g/90? g tablet. Lybrel (Wyeth Pharmaceuticals). Pregnancy. US.

More from news
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics